ZIOPHARM Oncology, Inc. (ZIOP) Reaches $4.16 After 3.00% Up Move; Synovus Financial Has Cut Western Digital (Call) (WDC) Position

December 7, 2017 - By Linda Rogers

The stock of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is a huge mover today! The stock increased 3.88% or $0.16 during the last trading session, reaching $4.16. About 876,765 shares traded. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) has risen 1.75% since December 7, 2016 and is uptrending. It has underperformed by 14.95% the S&P500.The move comes after 5 months positive chart setup for the $584.33 million company. It was reported on Dec, 7 by Barchart.com. We have $4.28 PT which if reached, will make NASDAQ:ZIOP worth $17.53M more.

Synovus Financial Corp decreased Western Digital Corp (Call) (WDC) stake by 94.97% reported in 2017Q2 SEC filing. Synovus Financial Corp sold 9,432 shares as Western Digital Corp (Call) (WDC)’s stock rose 15.69%. The Synovus Financial Corp holds 500 shares with $44,000 value, down from 9,932 last quarter. Western Digital Corp (Call) now has $23.31B valuation. The stock increased 1.19% or $0.93 during the last trading session, reaching $78.79. About 632,179 shares traded. Western Digital Corporation (NASDAQ:WDC) has risen 125.85% since December 7, 2016 and is uptrending. It has outperformed by 109.15% the S&P500.

Among 4 analysts covering Ziopharm Oncology (NASDAQ:ZIOP), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Ziopharm Oncology had 6 analyst reports since December 4, 2015 according to SRatingsIntel. Wells Fargo upgraded the stock to “Market Perform” rating in Wednesday, August 10 report. The company was maintained on Wednesday, May 11 by Mizuho. Mizuho maintained ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) rating on Monday, January 25. Mizuho has “Neutral” rating and $6 target. The firm has “Underperform” rating by Wells Fargo given on Friday, December 4. The company was initiated on Thursday, June 2 by Raymond James.

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. The company has market cap of $584.33 million. The company, through its collaboration agreement with Intrexon Corporation, holds certain rights to IntrexonÂ’s synthetic immuno-oncology platform for use in the field of oncology, which includes a clinical stage product candidate, Ad-RTS-IL-12 evaluated for the treatment of metastatic melanoma, unresectable recurrent or metastatic breast cancer, and Grade III malignant glioma . It currently has negative earnings. The Company’s synthetic immuno-oncology platform employs an inducible gene-delivery system that enables controlled in vivo expression of genes that produce therapeutic proteins to treat cancer.

Analysts await ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) to report earnings on February, 15. They expect $-0.13 earnings per share, down 18.18% or $0.02 from last year’s $-0.11 per share. After $-0.13 actual earnings per share reported by ZIOPHARM Oncology, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since June 12, 2017, it had 0 insider purchases, and 1 insider sale for $962,385 activity. CORDANO MICHAEL D had sold 11,322 shares worth $962,385.

Synovus Financial Corp increased Ishares Tr (IVV) stake by 1,336 shares to 6,480 valued at $1.58M in 2017Q2. It also upped Ubs Group Ag (NYSE:UBS) stake by 19,128 shares and now owns 88,993 shares. Alphabet Inc was raised too.

Investors sentiment increased to 1.12 in 2017 Q2. Its up 0.11, from 1.01 in 2017Q1. It increased, as 41 investors sold WDC shares while 243 reduced holdings. 101 funds opened positions while 216 raised stakes. 233.59 million shares or 1.07% more from 231.11 million shares in 2017Q1 were reported. Shufro Rose Com owns 7,374 shares for 0.07% of their portfolio. Caxton Assocs Limited Partnership has 16,200 shares for 0.01% of their portfolio. Oppenheimer & invested 0.03% of its portfolio in Western Digital Corporation (NASDAQ:WDC). Sprott Inc stated it has 0.41% of its portfolio in Western Digital Corporation (NASDAQ:WDC). Lumina Fund Mgmt Ltd, New York-based fund reported 10,000 shares. Bowen Hanes & Incorporated stated it has 2,855 shares or 0.01% of all its holdings. New Mexico Educational Retirement Board has invested 0.11% in Western Digital Corporation (NASDAQ:WDC). State Street holds 11.79 million shares. 5,729 were accumulated by Raymond James Na. 27,352 are held by Cubist Systematic Strategies Lc. Cypress Cap Management Ltd Liability Com (Wy) accumulated 200 shares or 0% of the stock. Synovus Financial reported 10,939 shares. Cwm Ltd holds 337 shares. Freestone Capital Hldg Limited owns 8,863 shares or 0.06% of their US portfolio. Smithfield Trust owns 483 shares for 0.01% of their portfolio.

Analysts await Western Digital Corporation (NASDAQ:WDC) to report earnings on January, 24. They expect $3.36 earnings per share, up 69.70% or $1.38 from last year’s $1.98 per share. WDC’s profit will be $993.84M for 5.86 P/E if the $3.36 EPS becomes a reality. After $3.28 actual earnings per share reported by Western Digital Corporation for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com